Study: New HIV combination treatment easier to tolerate

01/19/2006 | HealthDay News

A study comparing a new three-drug treatment for HIV/AIDS patients with an older drug regimen in use since the mid-1990s shows the newer combination caused fewer side effects and was easier for patients to tolerate. The study, reported in the New England Journal of Medicine, tenofovir DF, emtricitabine and efavirenz, which currently are available in two pills and may be combined in one pill soon, the researchers said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ